Delivery Order SPE2DR25D1053-SPE2DR26FT218
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,953.56 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count). The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is scheduled for completion by August...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,414.63 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on September 23, 2025, with completion scheduled for September 24, 2025. This competitive award, utilizing firm fixed-price pricing with no set-aside designation, represents a child order under AmerisourceBergen's significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,352.35 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,531.37 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on September 26, 2025, with a completion date of September 29, 2025. The contract employs firm fixed-price pricing and includes no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a ceiling value of $2,959.31. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 29, 2025. AmerisourceBergen Drug Corp will fulfill this order from its facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules in a 90-count package, with a ceiling value of $2,399.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $1,064.58 delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $3,408.77 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count supply) on May 30, 2025, with completion targeted for June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (30-count) with a ceiling value of $1,322.77. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award under open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $12,297.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT218Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,179.91 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) on October 22, 2025. This competitively awarded, non-set-aside order utilizes firm fixed pricing and is scheduled for completion by October 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capacity to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices. As a prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with DLA planning to establish next-generation regional contracts that may involve multiple award recipients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 10/22/25 |